PARATEK PHARMACEUTICALS INC's ticker is and the CUSIP is 699374AB0. A total of 21 filers reported holding PARATEK PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $97,874 | +34.1% | 100,000 | 0.0% | 0.00% | – |
| Q1 2023 | $72,977 | -16.0% | 100,000 | 0.0% | 0.00% | – |
| Q4 2022 | $86,920 | -1.2% | 100,000 | 0.0% | 0.00% | – |
| Q3 2022 | $88,000 | +3.5% | 100,000 | 0.0% | 0.00% | – |
| Q2 2022 | $85,000 | -3.4% | 100,000 | 0.0% | 0.00% | – |
| Q1 2022 | $88,000 | – | 100,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PenderFund Capital Management Ltd. | 21,060,000 | $24,802,000 | 5.63% |
| SILVERBACK ASSET MANAGEMENT LLC | 8,207,000 | $7,550,000 | 0.90% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 35,615,000 | $32,321,000 | 0.71% |
| DeepCurrents Investment Group LLC | 11,621,000 | $10,631,000 | 0.33% |
| AGF Investments LLC | 4,000,000 | $3,651,000 | 0.31% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 25,000,000 | $22,780,000,000 | 0.22% |
| WATER ISLAND CAPITAL LLC | 2,250,000 | $2,071,000 | 0.11% |
| L & S Advisors Inc | 935,000 | $853,000 | 0.09% |
| Sculati Wealth Management, LLC | 200,000 | $183,000 | 0.09% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,192,000 | $2,909,000 | 0.06% |